Other languages Zhejiang CONBA Pharmaceutical Co.,Ltd.

Equities

600572

CNE000001H86

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
4.92 ^CNY	+0.20%		+0.41%	-2.57%

Apr. 19	Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 01	Tranche Update on Zhejiang CONBA Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 23, 2024.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19
Shanghai-Listed Firms Actively Repurchase Shares as Regulators Focus on Market Value	Feb. 01
Zhejiang CONBA Pharmaceutical Co.,Ltd. announces an Equity Buyback for CNY 400 million worth of its shares.	Jan. 22
Zhejiang CONBA Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	Jan. 21
CONBA Pharma Gets Nod to Trial Cough Medicine	Nov. 28
CONBA Pharma Unit's Acetyl Cysteine Granules Chosen for China's Centralized Drug Procurement	Nov. 08
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-04
Wuxi China Life Chengda Equity Investment Center (Limited Partnership) and Jinhua Future Yicai Phase I Equity Investment Partnership (Limited Partnership) completed the acquisition of 7.84% stake in Jiangxi Zhenshiming Pharmaceutical Co., Ltd. from Zhejiang CONBA Pharmaceutical Co.,Ltd.	23-07-06
CONBA Pharma Gets Drug Registration for Risperidone Oral Solution	23-05-25
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-14
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-14
Zhejiang CONBA Pharmaceutical to Sell 7.8% Stake in Pharma Firm	23-03-20
CONBA Pharma's Azithromycin for Injection Passes Drug Regulator's Evaluation	23-02-24
CONBA Pharmaceutical Unit Sells Land For $17 Million	22-11-23
CONBA Pharmaceutical Unit Gets Regulator's Nod For Acetylcysteine Granules.	22-11-23
CONBA Pharmaceutical to Buy $62 Million Shares in Zhejiang International	22-10-26
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25
Zhejiang CONBA Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zhejiang CONBA Pharmaceutical Co.,Ltd.

Equities

600572

CNE000001H86

Other languages

Filters